Literature DB >> 17188506

Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.

David L Tamang1, Doug Redelman, Bryce N Alves, Leanne Vollger, Christy Bethley, Dorothy Hudig.   

Abstract

The purpose of these studies was to determine the minimal requirements to induce granzyme B, cytotoxic granules and perforin-dependent lytic capacity. To our surprise, both IL-2 and IL-15 induced not only proliferation, but also profound granzyme B and lytic capacity from CD8+ T cells in the absence of antigen or TCR-stimulation. Mouse splenocytes were incubated with mouse r-IL-2 or r-IL-15 for three days, tested by anti-CD3 redirected lysis and examined for intracellular granzyme B and for T cell activation markers. With 10(-8) M IL-2 or IL-15, there was excellent lytic activity at 1:1 effector to target ratios mediated by T cells from wild-type but not from perforin-gene-ablated mice, consistent with multiclonal activation. Lower interleukin concentrations induced less lytic activity. Granzyme B was undetectable on day 0, and greatly elevated on day 3 in CD44hi CD8+ T cells as detected by flow cytometry. Cytokines alone elevated the granzyme B as much as concanavalin A combined with the cytokines. Some ex vivo CD8+ T cells were CD122+, as were the cultured granzyme B+ cells, thus both populations had low-affinity receptors for the interleukins. Only some of the activated cells were proliferating as detected by CFSE labeling. When the cytokines were withdrawn, the cells lost lytic activity within 24 h and then within the next 24 h, died. Our results suggest that high concentrations of either IL-2 or IL-15 will activate the lytic capacity and granzyme B expression of many T cells and that antigen recognition is not required.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188506      PMCID: PMC1850105          DOI: 10.1016/j.cyto.2006.11.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  62 in total

1.  Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells.

Authors:  Y Tagaya; J D Burton; Y Miyamoto; T A Waldmann
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

2.  CD2 rescues T cells from T-cell receptor/CD3 apoptosis: a role for the Fas/Fas-L system.

Authors:  E Ayroldi; G Migliorati; L Cannarile; R Moraca; D V Delfino; C Riccardi
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

3.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

4.  Activation of naive and memory T cells by interleukin-15.

Authors:  H Kanegane; G Tosato
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

5.  In vivo regulation of murine granzyme B gene transcription in activated primary T cells.

Authors:  C K Babichuk; B L Duggan; R C Bleackley
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

6.  Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

Authors:  X Zhang; S Sun; I Hwang; D F Tough; J Sprent
Journal:  Immunity       Date:  1998-05       Impact factor: 31.745

7.  In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection.

Authors:  K Murali-Krishna; J D Altman; M Suresh; D Sourdive; A Zajac; R Ahmed
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

8.  Role of co-stimulation in CD8+ T cell activation.

Authors:  N Pardigon; N Bercovici; S Calbo; E C Santos-Lima; R Liblau; P Kourilsky; J P Abastado
Journal:  Int Immunol       Date:  1998-05       Impact factor: 4.823

9.  Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes.

Authors:  D M Anderson; S Kumaki; M Ahdieh; J Bertles; M Tometsko; A Loomis; J Giri; N G Copeland; D J Gilbert; N A Jenkins
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

10.  Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells.

Authors:  Z Cai; H Kishimoto; A Brunmark; M R Jackson; P A Peterson; J Sprent
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

View more
  34 in total

1.  Interleukin-15 enhances T-cell responses by stimulation with dendritic cells.

Authors:  Yu Zhao; Ke Cheng; Yang Wu; Xing-Chen Peng; Ye Chen; Ben-Xu Tan; Jun Ge; Hang Dong; Meng Wei; Feng Gao; Jing-Mei Su; Jian-Mei Hou; Ji-Yan Liu
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

Review 2.  Strategies to enhance NK cell function for the treatment of tumors and infections.

Authors:  Jacquelyn Freund-Brown; Leilani Chirino; Taku Kambayashi
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

3.  Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses.

Authors:  William H D Hallett; Erik Ames; Maite Álvarez; Isabel Barao; Patricia A Taylor; Bruce R Blazar; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

4.  T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules.

Authors:  Navtej Kaur; Osama S Naga; Håkan Norell; Amir A Al-Khami; Matthew J Scheffel; Nitya G Chakraborty; Christina Voelkel-Johnson; Bijay Mukherji; Shikhar Mehrotra
Journal:  Cytokine       Date:  2011-05-23       Impact factor: 3.861

5.  IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.

Authors:  Souheil-Antoine Younes; Michael L Freeman; Joseph C Mudd; Carey L Shive; Arnold Reynaldi; Soumya Panigrahi; Jacob D Estes; Claire Deleage; Carissa Lucero; Jodi Anderson; Timothy W Schacker; Miles P Davenport; Joseph M McCune; Peter W Hunt; Sulggi A Lee; Sergio Serrano-Villar; Robert L Debernardo; Jeffrey M Jacobson; David H Canaday; Rafick-Pierre Sekaly; Benigno Rodriguez; Scott F Sieg; Michael M Lederman
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

6.  Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance.

Authors:  Andrew L Doedens; Mark P Rubinstein; Emilie T Gross; J Adam Best; David H Craig; Megan K Baker; David J Cole; Jack D Bui; Ananda W Goldrath
Journal:  Cancer Immunol Res       Date:  2016-08-02       Impact factor: 11.151

7.  Essential role of CD11a in CD8+ T-cell accumulation and activation in adipose tissue.

Authors:  Erlie Jiang; Xiaoyuan Dai Perrard; Donglin Yang; Ilvira M Khan; Jerry L Perrard; C Wayne Smith; Christie M Ballantyne; Huaizhu Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-24       Impact factor: 8.311

8.  Human monocytes have increased IFN-γ-mediated IL-15 production with age alongside altered IFN-γ receptor signaling.

Authors:  Naeun Lee; Min Sun Shin; Ki Soo Kang; Seung-Ah Yoo; Subhasis Mohanty; Ruth R Montgomery; Albert C Shaw; Insoo Kang
Journal:  Clin Immunol       Date:  2014-03-19       Impact factor: 3.969

9.  Novel roles for IL-15 in T cell survival.

Authors:  Erik L Brincks; David L Woodland
Journal:  F1000 Biol Rep       Date:  2010-09-08

10.  Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway.

Authors:  Olga V Efimova; Todd W Kelley
Journal:  BMC Immunol       Date:  2009-11-22       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.